Source: iQoncept / Shutterstock
Genmab (NASDAQ:GMAB) just reported results for the first quarter of 2024.
- Genmab reported earnings per share of 29 cents. This was above the analyst estimate for EPS of 14 cents.
- The company reported revenue of $600.44 million.
- This was 3.98% better than the analyst estimate for revenue of $577.46 million.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/gmab-stock-earnings-genmab-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC